ストックスクリーナーアプリを入手
813.53
0.80%
-6.57
プレマーケット:
811.86
-1.67
-0.21%
Lilly Eli Co (LLY) 最新ニュース
Eli Lilly to invest $1.2 billion to expand manufacturing - San Juan Daily Star
Forex Signals Oct 30: BoJ, ECB Steady, Trump Meets Xi; Apple, Amazon, and Eli Lilly Q3 - FXLeaders
Eli Lilly partners with Walmart to sell weight loss drug directly to patients nationwide - Fox Business
Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal - Barron's
Lilly Takes Big Step Forward In AI With NVIDIA Partnership - Citeline News & Insights
Eli Lilly (LLY) Anticipates Strong Q3 Earnings Surge - GuruFocus
Eli Lilly Vows $1.2 Billion for Puerto Rico in Reshoring Boom - Bloomberg.com
Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug - Stocktwits
Eli Lilly to Invest $1.2 Billion in Puerto Rico Manufacturing Expansion - Yahoo! Finance Canada
Eli Lilly (LLY) Invests $1.2 Billion in Puerto Rico Manufacturing Plant - TipRanks
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer - Pharmaceutical Executive
Eli Lilly Advances AI And Access: Supercomputer With NVIDIA, Zepbound Via Walmart - Benzinga
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound - CNBC
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer - Pharmaceutical Technology
Eli Lilly Pours $1.2 Billion Into Puerto Rico Expansion - Finimize
Eli Lilly, Walmart launch retail pick-up option for weight loss drug Zepbound - Fierce Healthcare
Eli Lilly’s New Study: Potential Breakthrough in Type 1 Diabetes Prevention - TipRanks
NVIDIA hits $5T valuation, teams up with Lilly to build AI supercomputer - Mobi Health News
Lilly plans $1.2B expansion in Puerto Rico, adding 100 manufacturing jobs - Inside INdiana Business
Eli Lilly Commits Over $1.2 Billion to Expand Puerto Rico Manufacturing Hub - BioSpectrum Asia
Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push - WTVB
Eli Lilly to invest historic $1.2 Billion in expansion - The Weekly Journal
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide - Drug Topics
Jim Cramer on Eli Lilly Stock “Needs Some Kind of Catalyst to Get Things Going” - Yahoo! Finance UK
Lilly aligns with Walmart in bid to broaden access to discounted Zepbound - BioPharma Dive
Lilly, Walmart launch discount retail option for weight-loss drug Zepbound - Reuters
Eli Lilly, Walmart partner to bring Zepbound to customers with direct-to-consumer pricing - KIRO 7 News Seattle
Walmart, Eli Lilly partner to expand direct-to-consumer Zepbound pricing - Mass Market Retailers
Eli Lilly to Invest $1.2 Billion in Puerto Rico Plant Expansion - MarketScreener
Eli Lilly (LLY) Pours $1.2 Billion into Puerto Rico Expansion - GuruFocus
Eli Lilly to invest $1.2B in Puerto Rico plant - breakingthenews.net
Walmart and Eli Lilly to Offer In-Store Pickup for Zepbound With Direct-to-Consumer Pricing - PYMNTS.com
Lilly expands Zepbound direct-to-patient access through Walmart partnership - Indianapolis Business Journal
Lilly Announces Partnership with Walmart Pharmacy Launching First Retail Pick-Up Option Offering Direct-To-Consumer Priced Zepbound - Pharmaceutical Commerce
Eli Lilly announces over $1.2B investment in Puerto Rico faciliy - TipRanks
Eli Lilly invests $1.2 billion to expand Puerto Rico manufacturing site - StreetInsider
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States - MarketScreener
In Lilly vs Novo obesity drug battle, Trump price talks grab focus - MarketScreener
What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree? - The Globe and Mail
Eli Lilly (LLY) and Walmart Partner to Expand Access to Zepbound - GuruFocus
Eli Lilly, Walmart bring retail pick-up option with DTC pricing for Zepbound (WMT:NYSE) - Seeking Alpha
Eli Lilly strikes deal with Walmart to distribute cash-pay Zepbound vials - Sherwood News
Lilly, Walmart launch first retail pick-up option for weight-loss drug - Yahoo! Finance Canada
Lilly, Walmart Launch Discount Retail Option for Weight-Loss Drug Zepbound - US News Money
Eli Lilly Taps Nvidia to Build Pharma’s Most Powerful AI Supercomputer for Drug Discovery - WinBuzzer
Eli Lilly acquires Adverum to advance one-time gene therapy for vision loss - BioXconomy
Why Eli Lilly and Company stock is a strong buy callJuly 2025 Spike Watch & Accurate Trade Setup Notifications - Fundação Cultural do Pará
Top News Today: Lilly-NVIDIA AI Drug Discovery Deal, Sequoia’s $950M Fund Launch - Analytics Insight
Eli Lilly and Nvidia team up to build an AI supercomputer dedicated to drug discovery - MarketScreener
Eli Lilly partners with Nvidia to build AI supercomputer for drug discovery | Mint - Mint
Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential - NAI500
Lilly partners with Nvidia on AI supercomputer to speed up drug development - The Hindu
Eli Lilly (LLY) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Lilly, Nvidia team up to build pharma’s ‘most powerful’ supercomputer - Indianapolis Business Journal
How Omvoh’s FDA Approval at Eli Lilly (LLY) Has Changed Its Investment Story - Yahoo Finance
Eli Lilly and Company unveils Milan-Cortina athlete roster - Sports Business Journal
Eli Lilly (LLY) Partners with Nvidia for AI-Driven Drug Discover - GuruFocus
Lilly says it’s building pharma’s most powerful AI supercomputer with Nvidia - R&D World
Eli Lilly, J&J working with Nvidia to boost AI capabilities (LLY:NYSE) - Seeking Alpha
Eli Lilly and Company Partners with Nvidia to Build the Most Powerful Ai Supercomputer, Supercharging Medicine Discovery and Delivery for Patients - MarketScreener
Eli Lilly, NVIDIA team up to build pharma’s biggest AI supercomputer - statnews.com
Eli Lilly And Nvidia Build A Supercomputer For Drug Discovery - Finimize
NVIDIA (NVDA.US) partners with Eli Lilly and Co (LLY.US) to develop an AI-powered supercomputer for pharmaceutical applications. - 富途牛牛
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients - Investing News Network
Lilly keeps up legal fight against GLP-1 compounders - Endpoints News
Eli Lilly partners with Nvidia to build pharma’s most powerful AI supercomputer - TradingView
Eli Lilly and Nvidia team up to build 'most powerful' supercomputer in pharma - Fierce Biotech
0.18%
大文字化:
|
ボリューム (24 時間):